Skip to main content
Smart Investors Daily
Xcelerate Inc. logo

OTC · XCRT

Xcelerate Inc.

Healthcare · Medical - Care Facilities

$0.02

Up+$0.00 (+11.00%)

Updated Sep 20, 2026, 10:38 AM

SID Score

5.6/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
4.9M
P/E ratio
-18.14
Dividend yield
0.00%
52-week range
$0.01 – $0.03
Volume
1.16M
Avg. volume
72.31K

Price performance

XCRT price history

1M range · 10 trading sessions · Daily adjusted prices

XCRT closed at $0.02 after 10 trading sessions, up 81.66% for the selected period.

Last close
$0.02
Period change
+81.66%
Period low
$0.01
Period high
$0.02
Daily close
View OHLC price history
XCRT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 18, 2026$0.018$0.0263$0.009$0.021.16M
Sep 17, 2026$0.0172$0.018$0.0172$0.01850K
Sep 16, 2026$0.0157$0.0172$0.0156$0.0172176.1K
Sep 15, 2026$0.015$0.0157$0.0122$0.015746.55K
Sep 14, 2026$0.0125$0.015$0.0125$0.015152.5K
Sep 9, 2026$0.011$0.0125$0.011$0.012475K
Sep 4, 2026$0.011$0.011$0.011$0.01117.5K
Sep 3, 2026$0.011$0.011$0.011$0.01110K
Sep 2, 2026$0.011$0.011$0.011$0.01180K
Aug 25, 2026$0.0102$0.011$0.0102$0.01130K

Latest XCRT news

The latest Smart Investors Daily articles mentioning XCRT.

XCRT research

Overview

Company profile and research snapshot.

Company profile

XCELERATE INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

accessnewswire.com · Oct 9, 2025

Xcelerate, Inc. Announces the Sale of its Majority Interest in ESN Group

MAULDIN, SC / ACCESS Newswire / October 9, 2025 / Xcelerate, Inc. (OTC Markets:XCRT) today announced the sale of its majority interest in the ESN Group of companies, including ESN Group, Inc. and California Skin Research, Inc to Noble Labs Holdings, LLC, a company that had previously provided funding and marketing support to ESN Group, Inc. The transaction was completed as an all-cash sale. "We made a decision to divest these assets in order to re-focus our business on our original mission of implementing an AI aided medical technology and virtual health care program in Africa through our majority owned subsidiary, AfiyaSasa Africa, LLC," said Mike O'Shea, Xcelerate's Chief Executive Officer.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.